JULIA P. GREGORY - 03 Oct 2022 Form 4 Insider Report for Biohaven Ltd. (BHVN)

Role
Director
Signature
/s/ George Clark, Attorney-in-Fact
Issuer symbol
BHVN
Transactions as of
03 Oct 2022
Transactions value $
-$14
Form type
4
Filing time
05 Oct 2022, 17:39:04 UTC
Previous filing
30 Sep 2022
Next filing
26 Oct 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BHVN Common Shares Options Exercise $19.9K +4.12K $4.84* 4.12K 03 Oct 2022 Direct
transaction BHVN Common Shares Options Exercise $21.4K +6K +145.62% $3.56* 10.1K 03 Oct 2022 Direct
transaction BHVN Common Shares Options Exercise $21K +9K +88.96% $2.33* 19.1K 03 Oct 2022 Direct
transaction BHVN Common Shares Options Exercise $27.5K +9K +47.08% $3.06* 28.1K 03 Oct 2022 Direct
transaction BHVN Common Shares Tax liability -$89.8K -12K -42.59% $7.50 16.1K 03 Oct 2022 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BHVN Stock Options (Right to Buy) Other +4.12K 4.12K 03 Oct 2022 Common Shares 4.12K $4.84 Direct F2
transaction BHVN Stock Options (Right to Buy) Other +6K 6K 03 Oct 2022 Common Shares 6K $3.56 Direct F2
transaction BHVN Stock Options (Right to Buy) Other +9K 9K 03 Oct 2022 Common Shares 9K $2.33 Direct F2
transaction BHVN Stock Options (Right to Buy) Other +9K 9K 03 Oct 2022 Common Shares 9K $3.06 Direct F2
transaction BHVN Stock Options (Right to Buy) Options Exercise $0 -4.12K -100% $0.00* 0 03 Oct 2022 Common Shares 4.12K $4.84 Direct F2
transaction BHVN Stock Options (Right to Buy) Options Exercise $0 -6K -100% $0.00* 0 03 Oct 2022 Common Shares 6K $3.56 Direct F2
transaction BHVN Stock Options (Right to Buy) Options Exercise $0 -9K -100% $0.00* 0 03 Oct 2022 Common Shares 9K $2.33 Direct F2
transaction BHVN Stock Options (Right to Buy) Options Exercise $0 -9K -100% $0.00* 0 03 Oct 2022 Common Shares 9K $3.06 Direct F2
transaction BHVN Stock Options (Right to buy) Award $0 +125K $0.00 125K 03 Oct 2022 Common Shares 125K $7.00 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These shares were withheld by the Issuer in connection with share settlement to cover the cost of the stock options.
F2 Effective as of a pro rata distribution by Biohaven Pharmaceutical Holding Company Ltd.. ("RemainCo") to holders of its common shares (the "Distribution") pursuant to the Separation and Distribution Agreement (the "Separation Agreement"), dated as of May 9, 2022, by and among RemainCo, the Issuer, and Pfizer Inc. ("Pfizer"), each outstanding option to purchase common shares of RemainCo was adjusted so that such option became an option to acquire common shares of the Issuer ("Common Shares") and an option to acquire RemainCo common shares. As a result, the Reporting Person acquired options to acquire the Issuer's Common Shares in an amount determined in accordance with the Separation Agreement
F3 The shares underlying this option vest in four equal installments on October 3, 2022, 2023, 2024, and 2025, subject to the Reporting Person's continuous service with the Issuer at each vesting date.